Literature DB >> 4601899

Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens.

M N Guentzel, L J Berry.   

Abstract

The susceptibility of suckling mice to oral infection with several different Vibrio cholerae was determined. Mice up to 10 days of age were uniformly susceptible to oral infection with 10(8) colony-forming units of virulent organisms. Age-dependent resistance occurred thereafter to a maximum at about 15 days of age. The efficacy of selected vaccines was compared by oral challenge of 8-day-old, passively immunized CFW mice. An Ogawa-derived ribosomal antigen was found to be superior to a commercial whole-cell vaccine or to purified cholera enterotoxin. The ribosomal antigen was 50- to 100-fold more protective than the other vaccines on a weight basis against otherwise lethal challenge with Ogawa, Inaba, or El Tor Ogawa serotypes.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4601899      PMCID: PMC414973          DOI: 10.1128/iai.10.1.167-172.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Mechanisms of antibacterial immunity against Vibrio cholerae in the intestinal tracts of baby mice.

Authors:  W Chaicumpa; D Rowley
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

2.  Protection against experimental cholera by antitoxin.

Authors:  N F Pierce; E A Kaniecki; R S Northrup
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

3.  Isolation of protective somatic antigen from Vibrio cholerae (Ogawa) ribosomal preparations.

Authors:  R Jensen; B Gregory; J Naylor; P Actor
Journal:  Infect Immun       Date:  1972-08       Impact factor: 3.441

4.  Experimental cholera in infant mice: protective effects of antibody.

Authors:  W Chaicumpa; D Rowley
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

5.  Serum-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.

Authors:  M R Venneman; L J Berry
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

6.  Preparation of highly immunogenic ribosomal fractions of Mycobacterium tuberculosis by use of sodium dodecyl sulfate.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

7.  Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

8.  Immunity to Vibrio cholerae in the mouse. I. Passive protection of newborn mice.

Authors:  D Pitkin; P Actor
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

9.  Antitoxic immunity in experimental cholera: observations with purified antigens and the rat foot edema model.

Authors:  R A Finkelstein; R C Hollingsworth
Journal:  Infect Immun       Date:  1970-05       Impact factor: 3.441

10.  Mechanism of Action of Intestinal Antibody in Experimental Cholera II. Antibody-Mediated Antibacterial Reaction at the Mucosal Surface.

Authors:  R Freter
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

View more
  22 in total

1.  Hemolysin and the multifunctional autoprocessing RTX toxin are virulence factors during intestinal infection of mice with Vibrio cholerae El Tor O1 strains.

Authors:  Verena Olivier; G Kenneth Haines; Yanping Tan; Karla J Fullner Satchell
Journal:  Infect Immun       Date:  2007-08-13       Impact factor: 3.441

2.  Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.

Authors:  P Hoops; N E Prather; J Berry; J M Ravel
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

3.  Motility as a virulence factor for Vibrio cholerae.

Authors:  M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

4.  Evaluation of surface components of Vibrio cholerae as protective immunogens.

Authors:  E R Eubanks; M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

5.  Mice with persistent gastrointestinal Candida albicans as a model for antifungal therapy.

Authors:  C Herrera; M N Guentzel
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

6.  Use of fluorescent antibody in studies of immunity to cholera in infant mice.

Authors:  M N Guentzel; L H Field; E R Eubanks; L J Berry
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

7.  Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.

Authors:  M Riottot; J M Fournier; J Pillot
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

8.  Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.

Authors:  Stefan Schild; Eric J Nelson; Andrew Camilli
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

9.  Vibrio factors cause rapid fluid accumulation in suckling mice.

Authors:  M Nishibuchi; R J Seidler; D M Rollins; S W Joseph
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

10.  Variability of protection in inbred mice induced by a ribosomal vaccine prepared from Salmonella typhimurium.

Authors:  M L Misfeldt; W Johnson
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.